COX-2 and NF-KB Overexpression Is Common in Pancreatic Cancer but Does Not Predict for COX-2 Inhibitors Activity in Combination With Gemcitabine and Oxaliplatin
Cascinu, Stefano, Scartozzi, Mario, Carbonari, Giovanna, Pierantoni, Chiara, Verdecchia, Lorena, Mariani, Cinzia, Squadroni, Michela, Antognoli, Stefania, Silva, Rosa Rita, Giampieri, Riccardo, BerardVolume:
30
Language:
english
Journal:
American Journal of Clinical Oncology
DOI:
10.1097/coc.0b013e318054675c
Date:
October, 2007
File:
PDF, 194 KB
english, 2007